CBX8 and hepatocellular carcinoma: Furthermore, a mechanism study confirmed that CBX8 directly binds to the EGR1 promoter, thus activating the AKT/β-catenin signaling pathway.[17] Gao et al found that the expression levels of CBX8 and BMI-1 is substantially higher in HCC tissues.